Enzo Biochem IncNYSE:ENZ
- LAST PRICE1.0300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0100/ 201
- Ask / Lots1.1000/ 100
- Open / Previous Close--- / 1.0300
- Day Range---
- 52 Week Range
- Volume1,785
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ENZ |
|---|---|---|
| 09:32 ET | 1568 | 1.06 |
| 09:39 ET | 500 | 1.0548 |
| 09:42 ET | 1000 | 1.0568 |
| 09:46 ET | 348 | 1.055 |
| 09:50 ET | 500 | 1.055 |
| 09:51 ET | 100 | 1.06 |
| 09:53 ET | 100 | 1.055 |
| 10:06 ET | 100 | 1.06 |
| 10:09 ET | 500 | 1.055 |
| 10:11 ET | 7300 | 1.05 |
| 10:15 ET | 100 | 1.05 |
| 10:24 ET | 195 | 1.05 |
| 10:29 ET | 1000 | 1.0402 |
| 10:31 ET | 200 | 1.05 |
| 10:44 ET | 5950 | 1.04 |
| 10:47 ET | 4200 | 1.0486 |
| 11:32 ET | 5000 | 1.0401 |
| 11:34 ET | 100 | 1.045 |
| 11:41 ET | 3728 | 1.035 |
| 11:48 ET | 1100 | 1.0376 |
| 11:54 ET | 500 | 1.03 |
| 12:14 ET | 300 | 1.03 |
| 12:19 ET | 1000 | 1.0242 |
| 12:21 ET | 500 | 1.025 |
| 12:33 ET | 1999 | 1.02 |
| 12:35 ET | 11700 | 1.025 |
| 12:37 ET | 2000 | 1.03 |
| 12:55 ET | 399 | 1.04 |
| 01:00 ET | 298 | 1.04 |
| 01:09 ET | 8967 | 1.06 |
| 01:20 ET | 100 | 1.06 |
| 01:33 ET | 148 | 1.055 |
| 01:42 ET | 100 | 1.06 |
| 01:44 ET | 5991 | 1.07 |
| 01:45 ET | 800 | 1.06 |
| 01:54 ET | 500 | 1.05 |
| 02:02 ET | 980 | 1.06 |
| 02:03 ET | 900 | 1.05 |
| 02:05 ET | 300 | 1.05 |
| 02:14 ET | 500 | 1.06 |
| 02:16 ET | 400 | 1.06 |
| 02:27 ET | 600 | 1.05 |
| 02:30 ET | 300 | 1.05 |
| 02:32 ET | 200 | 1.05 |
| 02:34 ET | 300 | 1.05 |
| 02:36 ET | 1350 | 1.05 |
| 02:38 ET | 900 | 1.04 |
| 02:41 ET | 500 | 1.04 |
| 02:43 ET | 300 | 1.04 |
| 02:45 ET | 300 | 1.04 |
| 02:48 ET | 300 | 1.04 |
| 02:50 ET | 300 | 1.04 |
| 02:52 ET | 300 | 1.04 |
| 02:54 ET | 1332 | 1.03 |
| 02:56 ET | 400 | 1.04 |
| 02:57 ET | 300 | 1.04 |
| 02:59 ET | 187 | 1.04 |
| 03:01 ET | 250 | 1.04 |
| 03:03 ET | 705 | 1.04 |
| 03:06 ET | 1000 | 1.02 |
| 03:08 ET | 942 | 1.02 |
| 03:14 ET | 200 | 1.03 |
| 03:15 ET | 100 | 1.03 |
| 03:17 ET | 800 | 1.04 |
| 03:21 ET | 5700 | 1.03 |
| 03:32 ET | 100 | 1.04 |
| 03:33 ET | 100 | 1.05 |
| 03:44 ET | 200 | 1.05 |
| 03:46 ET | 600 | 1.04 |
| 03:50 ET | 300 | 1.05 |
| 03:51 ET | 300 | 1.03 |
| 03:53 ET | 100 | 1.03 |
| 03:55 ET | 200 | 1.03 |
| 03:57 ET | 200 | 1.03 |
| 04:00 ET | 1318 | 1.03 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Enzo Biochem Inc | 53.8M | -5.3x | --- |
bluebird bio Inc | 71.9M | -0.2x | --- |
Aadi Bioscience Inc | 56.2M | -1.0x | --- |
Equillium Inc | 27.3M | -5.9x | --- |
Prenetics Global Ltd | 54.1M | -1.2x | --- |
Celularity Inc | 44.2M | -0.3x | --- |
Company Information
Enzo Biochem, Inc. is a global life science company. The Company's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through its global distribution network and licensing. The Company conducts its research and other product development efforts through internal research and collaborative relationships.
Contact Information
- Headquarters
- 60 EXECUTIVE BLVDFARMINGDALE, NY, United States 11735
- Phone
- 516-755-5500
- Fax
- ---
Executives
- Chairman of the Board
- Steven Pully
- Chief Executive Officer, Chief Operating Officer
- Kara Cannon
- Chief Financial Officer
- Patricia Eckert
- General Counsel, Secretary
- Matthew Kupferberg
- Director
- Jonathan Couchman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $53.8M |
|---|---|
Revenue (TTM) | $31.9M |
Shares Outstanding | 52.2M |
Dividend Yield | 9.62% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-0.19 |
Book Value | $1.07 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -38.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
